research Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.
Search
for
Sort by
Research
990-1000 / 1000+ resultsresearch THERAPEUTIC HOTLINE: Effectiveness of the association of cetirizine and topical steroids in lichen planus pilaris - an open-label clinical trial
This study found that combined therapy with cetirizine and topical steroids stabilized inflammation in most patients with lichen planus pilaris, though one patient experienced cardiac arrhythmia.
research Zolpidem-Associated Dermatitis Artefacta—An Unusual Cause of Cicatricial Alopecia
This case study reported a rare occurrence of cicatricial alopecia linked to zolpidem-induced sleep-related amnestic behavior, highlighting the importance of a comprehensive medication history for accurate diagnosis.
research How useful is ritlecitinib in alopecia areata?
Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.
research Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
In this case report, a severe case of pediatric alopecia areata was treated with topical ruxolitinib, a Janus kinase inhibitor, highlighting the limited but promising evidence for this treatment in children.
research Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia
This website listing states that casemedicalresearch.com is available for purchase and aims to offer comprehensive information on various topics, highlighting it as a potential resource.
research CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
In this study, researchers evaluated CS12192, a selective JAK3 inhibitor, in an alopecia areata mouse model and found it reversed hair growth inhibition comparably to baricitinib, with better safety and similar immune-modulating mechanisms.
research Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
This letter discusses the limited treatment options for pediatric alopecia areata and the lack of controlled studies for therapies like systemic and off-label immunosuppressive drugs, without reporting new clinical results.
research Drug pipeline 2Q22 — a downturn in approvals
This report highlights Amvuttra's approval for hATTR amyloidosis as a more convenient RNAi therapy, and Olumiant's attention as the first systemic drug for hair loss among recent developments.
research Application of Acyzol in the Context of Zinc Deficiency and Perspectives
This article reviews the potential of Acyzol, a zinc-containing drug, to treat and prevent zinc deficiency conditions, but it reports no new clinical findings.